APA (7th ed.) Citation

Geisler, B., Meltzer, S., Burger, E., Ree, A., & Aas, E. (2024). EE540 Cost-Effectiveness of Next Generation Sequencing to Select Microsatellite Stable/Mismatch Repair Proficient Metastatic Colorectal Cancer Patients for Immune Checkpoint Inhibitor Therapy. Value in Health, 27(12), S161. https://doi.org/10.1016/j.jval.2024.10.820

Chicago Style (17th ed.) Citation

Geisler, B., S. Meltzer, EA Burger, AH Ree, and E. Aas. "EE540 Cost-Effectiveness of Next Generation Sequencing to Select Microsatellite Stable/Mismatch Repair Proficient Metastatic Colorectal Cancer Patients for Immune Checkpoint Inhibitor Therapy." Value in Health 27, no. 12 (2024): S161. https://doi.org/10.1016/j.jval.2024.10.820.

MLA (9th ed.) Citation

Geisler, B., et al. "EE540 Cost-Effectiveness of Next Generation Sequencing to Select Microsatellite Stable/Mismatch Repair Proficient Metastatic Colorectal Cancer Patients for Immune Checkpoint Inhibitor Therapy." Value in Health, vol. 27, no. 12, 2024, p. S161, https://doi.org/10.1016/j.jval.2024.10.820.